My Companies
Notification
Account
Log Out
Login
Received BSE in-principle approval to issue 38,71,854 equity shares at Rs40 each (about Rs15.49 crore) on preferential basis to non-promoters via share swap. Context: advances pending share-swap acquisition with sizable dilution.
Arvaya Healthcare Approves ₹10 Crore DEFIB Institute IP Acquisition
Arvaya Healthcare Board Approves ₹210 Crore Rights Issue and SIGPL Acquisition